← Open Payments lookup

CAROLYN STOLTE: Open Payments

NPI 1285241653 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,204 in 44 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $26 · 2025 $5,204

Consulting: $3,150Food & beverage: $1,458Travel & lodging: $510Education: $86
CompanyPaymentsAmount
Eli Lilly and Company4$3,660
UCB, Inc.4$226
Regeneron Healthcare Solutions, Inc.7$214
Galderma Laboratories, L.P.6$210
ABBVIE INC.4$202
GENZYME CORPORATION3$184
Amgen Inc.3$122
Novartis Pharmaceuticals Corporation2$113
Organon LLC1$73
Lilly USA, LLC2$45

Products named: EBGLYSS, DUPIXENT, NEMLUVIO, OTEZLA, RINVOQ, Bimzelx, Rhapsido, SKYRIZI.

Industry payments across MD — which companies pay providers there.